Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs
Completed · Phase 3
Conditions studied: Lennox-Gastaut Syndrome
In brief
This study was designed to evaluate the cognitive effect, safety, and pharmacokinetics (PK) of rufinamide on Lennox-Gastaut Syndrome (LGS) inadequately controlled in pediatric participants already taking other anti-epileptic drugs.
Key facts
- Study ID
- NCT01405053
- Run by
- Eisai Inc.
- People needed
- 37
- Starts
- 2011-06-16
- Expected to finish
- 2015-11-02
- Last updated by the study team
- 2019-08-06
Who can join
Age: 1 and older, up to 3. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — San Diego, California, United States
- Study site — Aurora, Colorado, United States
- Study site — Washington D.C., District of Columbia, United States
- Study site — Gulf Breeze, Florida, United States
- Study site — Miami, Florida, United States
- Study site — Tampa, Florida, United States
- Study site — Wellington, Florida, United States
- Study site — Augusta, Georgia, United States
- Study site — Chicago, Illinois, United States
- Study site — Lexington, Kentucky, United States
- Study site — Shreveport, Louisiana, United States
- Study site — Lebanon, New Hampshire, United States
- Study site — Gibbsboro, New Jersey, United States
- Study site — Rochester, New York, United States
- Study site — Akron, Ohio, United States
- Study site — Akson, Ohio, United States
- Study site — Columbus, Ohio, United States
- Study site — Philadelphia, Pennsylvania, United States
- Study site — Pittsburgh, Pennsylvania, United States
- Study site — Austin, Texas, United States
- Study site — San Antonio, Texas, United States
- Study site — Norfolk, Virginia, United States
- Study site — Calgary, Alberta, Canada
- Study site — Edmonton, Alberta, Canada
- Study site — Toronto, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.